Feedback / Questions
RHX-317 - Rheos Medicines
https://www.businesswire.com/news/home/20220720005156/en/Rheos-Medicines-Receives-FDA-%E2%80%9CStudy-May-Proceed%E2%80%9D-Letter-to-Initiate-Phase-1-Clinical-Study-Under-its-Investigational-New-Drug-Application-for-RHX-317-for-Treatment-of-Autoimmune-and-Inflammatory-Diseases
Jul 20, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next